Abivax SA (ABVX)
124.03
+4.13
(+3.44%)
USD |
NASDAQ |
May 21, 16:00
124.29
+0.26
(+0.21%)
After-Hours: 19:59
Abivax EPS Diluted (Quarterly) : -1.215 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| DBV Technologies SA | -0.5577 |
| Nicox SA | -- |
| Cellectis SA | -0.1774 |
| Transgene SA | -- |
| Innate Pharma SA | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -95.40M |
| Total Expenses (Quarterly) | 95.40M |
| Enterprise Value | 9.234B |
| Earnings Yield | -4.36% |
| Normalized Earnings Yield | -3.819 |